AdAlta Ltd
Angus Tester is a seasoned professional with extensive experience in biotechnology and pharmaceuticals, currently serving as the Senior Director of Operations at AdAlta Ltd since October 2021. Angus has previously held key roles including Senior Manager of Projects and Programs and the Head of Product Evaluation at Exopharm Ltd, where efforts focused on the development of exosomes for therapeutic purposes. Additional experience includes positions at Telix Pharmaceuticals Limited as Preclinical Manager, overseeing projects aimed at addressing unmet needs in cancer management, and as Senior Scientist at Nexvet Biopharma, dedicated to veterinary biologics. Angus's career began with significant research roles at leading institutions, including St Vincent’s Institute of Medical Research and The University of British Columbia, after earning a PhD in Biochemistry from Monash University. Moreover, a Diploma of Business in Frontline Management was obtained from Melbourne Business School.
This person is not in any teams
AdAlta Ltd
AdAlta (ASX:1AD) is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease. AdAlta is utilising the power of its i-body technology platform to develop a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.